Anales de la RANM

204 A N A L E S R A N M R E V I S T A F U N D A D A E N 1 8 7 9 INFECCIÓN POR HANTAVIRUS Bouza E, et al. An RANM. 2026;143(02): 182 - 206 wich-ELISA and its comparison with specific IgM detection in sera of patients with hemorrha- gic fever with renal syndrome. Hybridoma (Lar- chmt). 2007;26(1):42-5. 207. Heider H, Ziaja B, Priemer C, Lundkvist A, Ne- yts J, Krüger DH, et al. A chemiluminescence detection method of hantaviral antigens in neu- tralisation assays and inhibitor studies. J Virol Methods. 2001;96(1):17-23. 208. Morii M, Yoshimatsu K, Arikawa J, Zhou G, Kariwa H, Takashima I. Antigenic characteri- zation of Hantaan and Seoul virus nucleocapsid proteins expressed by recombinant baculovi- rus: application of a truncated protein, lacking an antigenic region common to the two viru- ses, as a serotyping antigen. J Clin Microbiol. 1998;36(9):2514-21. 209. Elgh F, Lundkvist A, Alexeyev OA, Wadell G, Juto P. A major antigenic domain for the human humoral response to Puumala virus nucleo- capsid protein is located at the amino-terminus. J Virol Methods. 1996;59(1-2):161-72. 210. Green W, Feddersen R, Yousef O, Behr M, Smith K, Nestler J, et al. Tissue distribution of hanta- virus antigen in naturally infected humans and deer mice. J Infect Dis. 1998;177(6):1696-700. 211. Saksida A, Duh D, Korva M, Avsic-Zupanc T. Dobrava virus RNA load in patients who have hemorrhagic fever with renal syndrome. J Infect Dis. 2008;197(5):681-5. 212. Ferres M, Vial P, Marco C, Yanez L, Godoy P, Castillo C, et al. Prospective evaluation of hou- sehold contacts of persons with hantavirus car- diopulmonary syndrome in chile. J Infect Dis. 2007;195(11):1563-71. 213. Vial PA, Valdivieso F, Ferres M, Riquelme R, Rioseco ML, Calvo M, et al. High-dose intrave- nous methylprednisolone for hantavirus cardio- pulmonary syndrome in Chile: a double-blind, randomized controlled clinical trial. Clin Infect Dis. 2013;57(7):943-51. 214. Lagerqvist N, Hagström Å, Lundahl M, Nilsson E, Juremalm M, Larsson I, et al. Molecular Diag- nosis of Hemorrhagic Fever with Renal Syndro- me Caused by Puumala Virus. J Clin Microbiol. 2016;54(5):1335-9. 215. Hjelle B, Tórrez-Martínez N, Koster FT, Jay M, Ascher MS, Brown T, et al. Epidemiolo- gic linkage of rodent and human hantavirus genomic sequences in case investigations of hantavirus pulmonary syndrome. J Infect Dis. 1996;173(4):781-6. 216. Lee HW, Lee PW, Johnson KM. Isolation of the etiologic agent of Korean Hemorrhagic fever. J Infect Dis. 1978;137(3):298-308. 217. Kariwa H, Arikawa J, Takashima I, Isegawa Y, Yamanishi K, Hashimoto N. Enhancement of in- fectivity of hantavirus in cell culture by centrifu- gation. J Virol Methods. 1994;49(2):235-44. 218. Lundkvist A, Cheng Y, Sjölander KB, Niklasson B, Vaheri A, Plyusnin A. Cell culture adaptation of Puu- mala hantavirus changes the infectivity for its natural reservoir, Clethrionomys glareolus, and leads to ac- cumulation of mutants with altered genomic RNA S segment. J Virol. 1997;71(12):9515-23. 219. Nemirov K, Lundkvist A, Vaheri A, Plyusnin A. Adaptation of Puumala hantavirus to cell culture is associated with point mutations in the coding region of the L segment and in the noncoding regions of the S segment. J Virol. 2003;77(16):8793-800. 220. Plyusnina A, Plyusnin A. Recombinant Tula han- tavirus shows reduced fitness but is able to sur- vive in the presence of a parental virus: analysis of consecutive passages in a cell culture. Virol J. 2005;2:12. 221. Schmidt J, Jandrig B, Klempa B, Yoshimatsu K, Arikawa J, Meisel H, et al. Nucleocapsid protein of cell culture-adapted Seoul virus strain 80-39: analysis of its encoding sequence, expression in yeast and immuno-reactivity. Virus Genes. 2005;30(1):37-48. 222. LeDuc JW, Smith GA, Pinheiro FP, Vasconcelos PF, Rosa ES, Maiztegui JI. Isolation of a Hantaan- related virus from Brazilian rats and serologic evidence of its widespread distribution in South America. Am J Trop Med Hyg. 1985;34(4):810-5. 223. Antoniades A, Grekas D, Rossi CA, LeDuc JW. Isolation of a hantavirus from a severely ill pa- tient with hemorrhagic fever with renal syndro- me in Greece. J Infect Dis. 1987;156(6):1010-3. 224. Elliott LH, Ksiazek TG, Rollin PE, Spiropoulou CF, Morzunov S, Monroe M, et al. Isolation of the causative agent of hantavirus pulmonary syn- drome. Am J Trop Med Hyg. 1994;51(1):102-8. 225. Schmaljohn AL, Li D, Negley DL, Bressler DS, Turell MJ, Korch GW, et al. Isolation and initial characterization of a newfound hantavirus from California. Virology. 1995;206(2):963-72. 226. Lundkvist A, Wiger D, Hörling J, Sjölander KB, Plyusnina A, Mehl R, et al. Isolation and charac- terization of Puumala hantavirus from Norway: evidence for a distinct phylogenetic sublineage. J Gen Virol. 1998;79 ( Pt 11):2603-14. 227. Vulin J, Murri S, Madrières S, Galan M, Tatard C, Piry S, et al. Isolation and Genetic Characteri- zation of Puumala Orthohantavirus Strains from France. Pathogens. 2021;10(3). 228. Crowley MR, Katz RW, Kessler R, Simpson SQ, Levy H, Hallin GW, et al. Successful treatment of adults with severe Hantavirus pulmonary syn- drome with extracorporeal membrane oxygena- tion. Crit Care Med. 1998;26(2):409-14. 229. Wernly JA, Dietl CA, Tabe CE, Pett SB, Crandall C, Milligan K, et al. Extracorporeal membrane oxygenation support improves survival of pa- tients with Hantavirus cardiopulmonary syndro- me refractory to medical treatment. Eur J Car- diothorac Surg. 2011;40(6):1334-40. 230. Cornejo R, Ugalde D, Llanos O, Bisbal P, De la Barrera L, Romero C, et al. Prone Position Ventilation Used during a Transfer as a Bridge to Ecmo Therapy in Hantavirus-Induced Seve- re Cardiopulmonary Syndrome. Case Rep Crit Care. 2013;2013:415851. 231. Ulloa-Morrison R, Pavez N, Parra E, Lopez R, Mondaca R, Fernandez P, et al. Critical care management of hantavirus cardiopulmonary syndrome. A narrative review. J Crit Care. 2024;84:154867. 232. Dara SI, Albright RC, Peters SG. Acute sin nom- bre hantavirus infection complicated by renal failure requiring hemodialysis. Mayo Clin Proc. 2005;80(5):703-4.